ResearchPUBMEDMar 28
Macrophage Extracellular Vesicles: Therapeutic Strategies for Corneal Fibrosis in Rare Diseases.
Scientists are studying a new way to treat corneal scarring (clouding of the eye that causes blindness) using tiny particles called extracellular vesicles that come from immune cells called macrophages. This approach is being tested for rare genetic eye diseases like epidermolysis bullosa, KID syndrome, and aniridia, where the cornea becomes scarred due to chronic inflammation and genetic mutations. Current treatments don't work well and have significant side effects, so this new method could offer patients a better option.
WHY IT MATTERSFor patients with epidermolysis bullosa, KID syndrome, or aniridia experiencing corneal scarring, this research offers a potential new treatment strategy that could prevent blindness without the side effects of current therapies.